Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
322 Exam 3
322 Endocrine & Diabetes
| Term | Definition |
|---|---|
| levothyroxine | replacement therapy, increases levels of T4 and deionized to T3 |
| levothyroxine interventions | monitor height and weight in infants and children, take on an empty stomach, safe during pregnancy |
| liothyronine | synthetic T3, rapid onset; best absorbed in the GI tract; initial treatment for myxedema |
| methimazole | inhibits thyroid synthesis, does not destroy existing; avoid during pregnancy |
| methimazole side effect | agranulocytosis; report sore throat and fever |
| propylthiouracil | inhibits thyroid production and prevents conversion of T4 to T3; safe in 1st trimester of pregnancy; preferred for thyroid storm |
| propylthiouracil side effects | agranulocytosis, risk for liver injury |
| propylthiouracil administration | shorter half life; requires multiple doses per day |
| radioactive iodine thyroid cancer | high dose |
| radioactive iodine hyperthyroidism | low dose |
| somatropin | administered to a child before the epiphyses are fused; can be abused by athletes |
| somatropin side effects | paresthesia, glucose fluctuations |
| somatropin adverse reactions | seizures, intracranial hypertension, secondary malignancy |
| somatostatin | helps regulate GH release and is produced in the hypothalamus; can cause cardiac toxicity - bradycardia |
| dopamine agonist | inhibits secretion of GH caused by pituitary adenomas |
| dopamine agonist adverse effects | cardiac toxicity - hypertension, MI, angina; cerebrovascular toxicity |
| oral antidiabetics | sulfonylureas and biguanides |
| sulfonylureas | type 2, can be combined with other drugs |
| 1st generation sulfonylureas | associated with increased risk of cardiovascular disease |
| 2nd generation sulfonylureas | increase tissue response to insulin and decrease glucose production in the liver; glipizide and glyburide |
| 2nd generation sulf | longer duration of action and fewer side effects; greater hypoglycemia potency and cannot be used with liver or kidney dysfunction |
| biguanides | metformin, glucophage |
| metformin side effects | anorexia, N/V, decreased B12 levels and folic acid deficiency |
| metformin toxicity | lactic acidosis; drug interaction with alcohol and not recommended with renal impairment |
| metformin withheld | 48 hours before or after administration of IV contrast |
| external insulin pump | blood sugar check hourly, how to change tubing, know when to bolus |
| conscious hypoglycemia | fast acting oral sugar |
| unconscious hypoglycemia | IV glucose, parenteral glucagon |
Created by:
ahommel
Popular Nursing sets